Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tammenoms Bakker Juliet
Relationship:  
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   190,546    

Indirect Shares

   34,191,873      
Direct Value   $6,371,625    

Indirect Value

   $650,206,579      
Total Shares   34,382,419      
Total Value   $656,578,203      


Corcept Therapeutics Inc $3,751,111 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $236,425 Eargo, Inc. $0 Rxsight, Inc. $1,809,796 Corcept Therapeutics Inc $3,751,111 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $236,425 Eargo, Inc. $0 Rxsight, Inc. $1,809,796
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    13    

     Stock price went up :
    3   
    12    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   1.5   
   12.0   
     Percentage Gain/Loss :
   10.4%
 1,186.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Corcept Therapeutics Inc CORT 10% Owner 2016-12-15 133,539 2016-12-15 10,956,002    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-11-18 28,186    Premium*  
            Aimmune Therapeutics, Inc. AIMT 10% Owner 2018-02-22 16,651 2018-02-22 6,013,134    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2018-09-21 0 2020-08-28 3,202,530    Premium*  
            Axonics Modulation Technologies,... AXNX Director 2020-09-18 3,500 2020-09-18 1,956,359    Premium*  
            Venus Concept Inc VERO Director, 10% Owner 2019-11-07 0 2019-11-07 3,666,119    Premium*  
            Eargo, Inc. EAR Director, 10% Owner 2021-05-17 7,016 2021-05-17 3,008    Premium*  
            Tourmaline Bio TRML 10% Owner 2021-05-11 0 2021-05-11 3,220,775    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Rxsight, Inc. RXST 2024-02-14 29,840 2024-02-14 1,548    Premium*  
* Premium Members only  

Records found :    96         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-20 4 OE $2.77 $27,008 I/I 9,750 182,742 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-20 4 S $5.85 $3,105,063 D/D (530,780) 13,100,760 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-20 4 OE $2.77 $3,105,056 D/D 1,120,959 13,331,093 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-24 4 S $5.65 $3,132,066 D/D (554,348) 13,677,121 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-24 4 OE $2.77 $3,132,064 D/D 1,130,709 14,231,469 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-30 4 OE $4.05 $68,174 I/I 16,833 194,958 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2015-03-30 4 OE $4.05 $3,401,235 D/D 839,811 14,516,932 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-11-15 4 S $9.55 $29,558 I/I (3,094) 191,864 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-11-15 4 S $9.55 $1,474,653 D/D (154,359) 14,362,573 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-11-16 4 S $9.51 $3,252 I/I (342) 191,522 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-11-16 4 S $9.51 $162,142 D/D (17,052) 14,345,521 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-12-12 4 A $0.00 $0 D/D 204,210 204,210 0 -
CORT Corcept Therapeutics Inc 10% Owner   –       –       •   2016-12-15 4 GD $0.00 $0 D/D 70,671 133,539 0 -
EAR Eargo, Inc. Director   –       •       •   2020-10-20 4 B $18.00 $4,199,994 I/I 233,333 3,918,691 2.25 -
EAR Eargo, Inc. Director   –       •       •   2020-10-20 4 A $0.00 $0 I/I 3,685,358 3,685,358 0 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 A $0.00 $0 D/D 3,508 3,508 0 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 A $0.00 $0 I/I 1,504 1,504 0 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 AS $0.00 $0 I/I (1,000,000) 2,918,691 0 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 A $0.00 $0 I/I 1,504 3,008 0 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 D $0.00 $0 I/I (1,000,000) 1,918,691 0 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 A $0.00 $0 D/D 3,508 7,016 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,033,464 I/I 216,676 38,011 1.5 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 A $0.00 $0 I/I 1,717,720 33,753 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2014-10-07 4 S $30.04 $358,289 I/I (11,927) 37,776 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2014-10-09 4 S $30.00 $28,290 I/I (943) 37,757 0 -
  96  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us